Year: 2022
Reference No.: IB No. 2022-268
Category: Summary of Awarded Contract
Approved Budget for the Contract: 681,250,000.00
Awardee/Supplier: Zuellig Pharma Corporation – Interphil Laboratories, Inc., Joint Venture
Date of NOA: Friday, December 2, 2022
PO/Contract No.: GOP-C-2022-222
Effectivity and Expiration Date of Contract: Wednesday, December 14, 2022 to Wednesday, March 15, 2023
NTP Contract Date: Wednesday, December 14, 2022
Contract Period: 1st Tranche = 1,000,000 doses for 60 cd upon receipt of approved NTP and 2nd Tranche = 250,000 doses for 90 cd upon receipt of approved NTP
Name of Winning Bidder: Zuellig Pharma Corporation – Interphil Laboratories, Inc., Joint Venture
Official Business Address: KM.14 West Service Rd. SSH cor. Edison Ave., Brgy. Sun Valley, Paranaque City
Amount of Contract Awarded: 681,250,000.00
Date of Award: Friday, December 2, 2022
Date of Acceptance: Friday, December 2, 2022
Implementing Office/End-User Unit/s: Disease Prevention and Control Bureau
Date Posted: January 31, 2023